Steve Brozak

Steve Brozak (born 1961) is the Managing Partner and President of WBB Securities, LLC, a Democratic congressional candidate in the 2004 American election cycle, and was the Chairman and CEO of StormBio, Inc. Brozak was named a 2013 StarMine "Top Stock Picker" among Pharmaceutical Analysts by the Thomson Reuters Awards for Excellence, and was recognized by The Wall Street Journal as "Best on the Street" among Medical Equipment and Supplies financial analysts.

Brozak is a retired Lieutenant Colonel in the United States Marine Corps.

He served a three-year appointment to the Secretary of Navy's Navy and Marine Corps Retiree Council.

He also is a Fellow of Foreign Policy Association.

Brozak received his BA from Columbia University (1982), MBA from Columbia Business School (1994) and Doctor of Medical Humanities (DMH) from Drew University (2016).

Brozak is the President and Co-founder of WBB Securities, LLC, an independent broker dealer, investment bank and sell-side research firm.

WBB Securities focuses on healthcare, biotechnology, pharmaceutical and medical device research and banking.

WBB Securities and its analysts are ranked consistently as top performers in research accuracy.

Campaigning for Congress during the 2004 election, Brozak kicked off his campaign with a front-page feature story, "A Marine Jumps Party Lines to Join Democrats in Trenches", in The Wall Street Journal, where he gave early warning of the nearly insurmountable challenges faced by the shortage of U.S. troops in Iraq and the need for a modified strategy to subdue insurgency and create a secure nation in Iraq.

His campaign focused on the lack of planning for the Iraq war, the strain it placed on our military, and the severe economic repercussions that would ensue—specifically the rise in energy prices.

He also stressed the need for unfettered research in stem cells and the need for a fair trade policy with other countries.

Brozak was featured in an article in the magazine Salon, which described his campaign as "a referendum on Bush's military folly."

During his Congressional campaign, Brozak was invited to speak during prime time at the 2004 Democratic National Convention, where he criticized the Bush administration for lack of planning prior to the war in Iraq.

He was later criticized by bloggers in the Internet publication, The Weekly Standard for his strong position against administration partisanship in political appointments at the Pentagon.

Brozak was defeated by incumbent Mike Ferguson (Republican) for New Jersey's 7th Congressional District.

Brozak is a retired Lieutenant Colonel in the United States Marine Corps, having served in Europe, the Middle East, Asia, and the Caribbean.

He has been attached to units within the United Nations, specifically as a Foreign area officer at the U.S. Mission to the United Nations, and as a Public Information Officer in the United Nations Mission in Haiti (UNMIH).

Brozak was also attached to units within NATO (North Atlantic Treaty Organization) and has worked with the Inter-American Defense Board.

In 2010, he was named one of the Top Analysts in the Healthcare Sector for the United States by the Financial Times and StarMine.

They include: Fukushima Joins Titanic, Katrina as a Single Word for Disaster, March 16, 2011, Fukushima: A Nuclear Threat to Japan, the U.S. and the World, April 6, 2011 and Fukushima and Nuclear Power: Playing with Fire, April 25, 2011.

He also is the author of twelve analytical reports about the threat of pandemic influenza, has written guest editorials and been asked to speak about several issues, including the challenges facing large pharmaceutical companies, the need to restructure the U.S. Food and Drug Administration, and difficulties facing the U.S. healthcare system.

As being named 2013 StarMine "top stock picker" among Pharmaceutical Analysts, Brozak has achieved top-ranking recognition in all healthcare fields including Biotechnology, Medical Devices, and Pharmaceuticals over the last five years by the Thomson Reuters Awards for Excellence and The Wall Street Journal Best on the Street Survey.

He is a Fellow of the Foreign Policy Association.

Brozak has specific expertise and interest in human stem cell therapies, biothreat countermeasures, bacterium, and viruses such as highly pathogenic influenza, Marburg, and Ebola.

He is a contributor to Forbes, Businessweek, STAT, CNN, and ABCNews.com while regularly authoring articles in peer-reviewed and news publications.

Among articles are:

Brozak is frequently interviewed and quoted by such media sources as the Associated Press, ABC, Barron's, Bloomberg, CNN, Financial Times, Forbes, Dow Jones, Reuters, USA Today, TheStreet.com, and The Wall Street Journal.

He is featured in the British Medical Journal raising awareness among the cleanliness of endoscopic procedures within the United States.

He is co-author of three commentaries about the failure of the Fukushima Daichi nuclear power plants and the potential impact on the world, published by ABCNews.com.

Brozak participated in the production of two films- as an Associate Producer of Money for Nothing: Inside the Federal Reserve (2013) and as Executive Producer of American Veteran (2017).

Brozak was Chairman and CEO of StormBio, Inc, a development stage biotechnology company focused on the attenuation of Cytokine Storm, specifically in influenza.

StormBio was developing therapeutics to minimize the mortality and morbidity resulting from Highly Pathogenic Influenza infections, such as H5N1 and H1N1 influenza strains.

StormBio's approach was to modulate runaway inflammation.

Many of the deaths and much of the permanent damage from influenza is caused by a runaway inflammatory process called cytokine storm.

It was anticipated that StormBio's therapeutics also could be used to treat a variety of other inflammatory conditions.

StormBio was affiliated with leading scientists in the field of inflammation and had in-licensed intellectual property and novel therapeutics directed at treating people in the event of an influenza pandemic.

In September 2016, WBB Securities added an asset management arm to the firm, which subsequently launched a long/short equity healthcare fund named WBB Life Sciences l/s.

As president of WBB Securities, Brozak is responsible for the research and investment banking division.

He raises funds for public offerings in various healthcare sectors.

He has been ranked one of the top analysts of all First Call submitting analysts in all healthcare sectors over the past five years by the StarMine ranking system.